About 418 results

ALLMedicine™ Keratoacanthoma Center

Research & Reviews  144 results

Multiple eruptive squamoproliferative lesions during anti-PD1 immunotherapy for metasta...
Dermatologic Therapy; Star P, Jackett LA et. al.

Mar 30th, 2022 - Treatment with anti-PD1 inhibitors may enhance the risk for developing low grade squamoproliferative skin tumors. Immunohistochemical (IHC) analysis of the immune tumor microenvironment (TME) allows exploration of the pathogenesis and relationship...

Giant Keratoacanthoma of the Hand.
Journal of Cutaneous Medicine and Surgery; Prezzi T, Heck R

Mar 25th, 2022 - Giant Keratoacanthoma of the Hand.|2022|Prezzi T,Heck R,|

Keratoacanthoma or cutaneous squamous cell carcinoma revealing a DNA mismatch repair de...
Journal of the European Academy of Dermatology and Venere... Miao Y, Kolb F et. al.

Dec 3rd, 2021 - Keratoacanthoma (KA) and well-differentiated cutaneous squamous cell carcinoma (cSCC) are hardly distinguishable clinically and histologically. They both can be seen in patients with hereditary non-polyposis colorectal cancer (HNPCC) or Lynch Synd...

Squamous cell carcinoma and keratoacanthoma on the neck in a patient with hypohidrotic ...
European Journal of Dermatology : EJD; Suyama T, Shimomura Y et. al.

Nov 3rd, 2021 - Squamous cell carcinoma and keratoacanthoma on the neck in a patient with hypohidrotic ectodermal dysplasia.|2021|Suyama T,Shimomura Y,Yoshikawa S,Kamijo T,Komori S,|complications,pathology,complications,pathology,complications,pathology,complicat...

Debulking followed by intralesional 5-fluorouracil for the treatment of cutaneous squam...
Dermatologic Therapy; Hamad J, Jolly PS

Sep 23rd, 2021 - Debulking followed by intralesional 5-fluorouracil (deb-IL5FU) is a nonsurgical modality which has been used to treat skin cancer anecdotally for many years. There are few in depth studies examining this technique and success rate of intralesional...

see more →

News  23 results

Agminated Nodules on the Scalp
Lan Zhang, MD, Yang Yang, MD et. al.

Jul 14th, 2021 - The Diagnosis: Cutaneous Angiosarcoma Biopsy revealed a cellular neoplasm consisting of atypical polygonal cells with a hobnailed appearance, vasoformative characteristics, and rare extravasated erythrocytes. The tumor had an infiltrative growth p.

Combination Therapy in Mutated Melanoma

Apr 2nd, 2021 - Transcript: The big impact of MEK inhibitors has been 2-fold. One is that it delays resistance, which you know, you have this additional blockade for cells that have somehow managed to live without BRAF. And so they still need to overcome the ...

Dabrafenib/Trametinib Extends OS Versus Vemurafenib in Phase III Melanoma Trial

Dec 4th, 2020 - Rafael Amado, MD A phase III study comparing trametinib (Mekinist) plus dabrafenib (Tafinlar) with single-agent vemurafenib (Zelboraf) has been stopped early following a positive interim analysis, according to an announcement from GlaxoSmithKline...

Dabrafenib/Trametinib Combo Granted EU Approval for Advanced Melanoma

Jun 30th, 2020 - Bruno Strigini The combination of dabrafenib (Tafinlar) plus trametinib (Mekinist) has been approved by the European Commission for the treatment of patients with unresectable or metastatic BRAF V600­—positive melanoma, according to a stateme...

Angiosarcoma Imitating a Morpheaform Basal Cell Carcinoma
Elizabeth Veasey, MD, Soon Bahrami, MD et. al.

Mar 2nd, 2020 - To the Editor: Basal cell carcinoma (BCC) is the most common of the nonmelanoma skin cancers and is a highly curable skin growth. 1,2 Conversely, angiosarcomas are aggressive vascular tumors of endothelial origin that classically appear as reddish.

see more →